| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13715* | 2021 |
| Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis K Wouters, PJ van Gorp, V Bieghs, MJ Gijbels, H Duimel, D Lütjohann, ... Hepatology 48 (2), 474-486, 2008 | 580 | 2008 |
| The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management T Yadati, T Houben, A Bitorina, R Shiri-Sverdlov Cells 9 (7), 1679, 2020 | 387 | 2020 |
| Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates R Shiri-Sverdlov, K Wouters, PJ van Gorp, MJ Gijbels, B Noel, L Buffat, ... Journal of hepatology 44 (4), 732-741, 2006 | 224 | 2006 |
| LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease V Bieghs, PJ Van Gorp, K Wouters, T Hendrikx, MJ Gijbels, M van Bilsen, ... PloS one 7 (1), e30668, 2012 | 211 | 2012 |
| Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice K Wouters, R Shiri-Sverdlov, PJ van Gorp, M van Bilsen, MH Hofker Clinical Chemistry and Laboratory Medicine (CCLM) 43 (5), 470-479, 2005 | 207 | 2005 |
| Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice V Bieghs, K Wouters, PJ Van Gorp, MJJ Gijbels, MPJ De Winther, ... Gastroenterology 138 (7), 2477-2486. e3, 2010 | 191 | 2010 |
| Nonalcoholic fatty liver disease: a main driver of insulin resistance or a dangerous liaison? N Gruben, R Shiri-Sverdlov, DPY Koonen, MH Hofker Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1842 (11 …, 2014 | 178 | 2014 |
| Plant-based sterols and stanols in health & disease:“Consequences of human development in a plant-based environment?” J Plat, S Baumgartner, T Vanmierlo, D Lütjohann, KL Calkins, DG Burrin, ... Progress in lipid research 74, 87-102, 2019 | 159 | 2019 |
| Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort JV van Vliet-Ostaptchouk, R Shiri-Sverdlov, A Zhernakova, E Strengman, ... Diabetologia 50 (1), 59-62, 2007 | 158 | 2007 |
| Exendin‐4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration Y Wang, ET Parlevliet, JJ Geerling, SJL Van der Tuin, H Zhang, V Bieghs, ... British journal of pharmacology 171 (3), 723-734, 2014 | 138 | 2014 |
| Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells V Bieghs, F Verheyen, PJ van Gorp, T Hendrikx, K Wouters, D Lütjohann, ... PloS one 7 (3), e34378, 2012 | 138 | 2012 |
| Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids AWF Janssen, T Houben, S Katiraei, W Dijk, L Boutens, N van Der Bolt, ... Journal of lipid research 58 (7), 1399-1416, 2017 | 130 | 2017 |
| NAFLD preclinical models: more than a handful, less of a concern? Y Oligschlaeger, R Shiri-Sverdlov Biomedicines 8 (2), 28, 2020 | 127 | 2020 |
| Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice SS Rensen, V Bieghs, S Xanthoulea, E Arfianti, JA Bakker, ... PloS one 7 (12), e52411, 2012 | 127 | 2012 |
| Non-alcoholic steatohepatitis: the role of oxidized low-density lipoproteins SMA Walenbergh, GH Koek, V Bieghs, R Shiri-Sverdlov Journal of hepatology 58 (4), 801-810, 2013 | 125 | 2013 |
| Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice K Wouters, M van Bilsen, PJ van Gorp, V Bieghs, D Lütjohann, A Kerksiek, ... FEBS letters 584 (5), 1001-1005, 2010 | 124 | 2010 |
| Specific immunization strategies against oxidized low‐density lipoprotein: a novel way to reduce nonalcoholic steatohepatitis in mice V Bieghs, PJ van Gorp, SMA Walenbergh, MJ Gijbels, F Verheyen, ... Hepatology 56 (3), 894-903, 2012 | 122 | 2012 |
| Inflammatory bowel disease: a stressed “gut/feeling” Y Oligschlaeger, T Yadati, T Houben, CM Condello Oliván, ... Cells 8 (7), 659, 2019 | 115 | 2019 |
| NASH and atherosclerosis are two aspects of a shared disease: central role for macrophages V Bieghs, PCN Rensen, MH Hofker, R Shiri-Sverdlov Atherosclerosis 220 (2), 287-293, 2012 | 113 | 2012 |
Marten HofkerProfessor of Molecular Genetics, UMCG, Groningen University, The Netherlandsumcg.nl의 이메일 확인됨
